HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by John, S. Articles by Krishnaswami, S. Search for Related Content PubMed PubMed Citation Articles by John, S. Articles by Krishnaswami, S.

The Journal of Thoracic and Cardiovascular Surgery, Vol 99, 631-638, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Valve replacement in the young patient with rheumatic heart disease. Review of a twenty-year experience

S John, E Ravikumar, PS Jairaj, U Chowdhury and S Krishnaswami
Department of Thoracic and Cardiovascular Surgery, Christian Medical College Hospital, Vellore, India.

During a 20-year period 303 young subjects between 9 and 20 years of age (mean, 16.2 +/- 2.72 years) with rapid and relentlessly progressive valvular disease from rheumatic fever underwent valve replacements. The Starr-Edwards ball valve prosthesis remains the device of choice, although other valves have been implanted. The overall hospital mortality rate was 9.6% in the mitral valve, 3.5% in the aortic valve, and 4.2% in the double valve replacement groups. Actuarial survival at 10, 15, and 20 years was 78.4% (+/- 3.3%), 70.0% (+/- 5.8%), and 59.3% (+/- 11.1%), respectively, for patients with mitral valve replacement. The rates for aortic valve replacement were 85.9% (+/- 4.6%) at 10 and 15 years and 72.7% (12.8%) at 20 years. In the double valve replacement group the survival rates after 5 and 10 years were 79.9% (+/- 5.1%). The incidence of thromboembolism was 0.41, 0.59, and 1.04 per 100 patient-years for the mitral, aortic, and double-valve prostheses, respectively. The prospect of childbearing seems promising in those young women who were subsequently married. Our favorable and gratifying experience in this review bears testimony to the physiologic advantages of the Starr-Edwards valve as the device of choice in the rehabilitation of patients with advanced and severe valvular disease after rheumatic fever.

This article has been cited by other articles:

				R. P Akhtar, A. R Abid, H. Zafar, S. S Sheikh, M. A Cheema, and J. S Khan Prosthetic Valve Replacement in Adolescents with Rheumatic Heart Disease Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 476 - 481. [Abstract] [Full Text] [PDF]

				N. D. Hillman, L. Y. Tani, L. G. Veasy, L. L. Lambert, G. B. Di Russo, D. B. Doty, E. C. McGough, and J. A. Hawkins Current Status of Surgery for Rheumatic Carditis in Children Ann. Thorac. Surg., October 1, 2004; 78(4): 1403 - 1408. [Abstract] [Full Text] [PDF]

				J.-M. Grinda, C. Latremouille, N. D'Attellis, A. Berrebi, S. Chauvaud, A. Carpentier, J.-N. Fabiani, and A. Deloche Triple valve repair for young rheumatic patients Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 447 - 452. [Abstract] [Full Text] [PDF]

				S. John, E. Ravikumar, C. N. John, and V. V. Bashi 25-year experience with 456 combined mitral and aortic valve replacement for rheumatic heart disease Ann. Thorac. Surg., April 1, 2000; 69(4): 1167 - 1172. [Abstract] [Full Text] [PDF]

				B. Gometza and C. M. G. Duran Ball Valve (Smeloff-Cutter) Aortic Valve Replacement Without Anticoagulation Ann. Thorac. Surg., November 1, 1995; 60(5): 1312 - 1316. [Abstract] [Full Text]